(MedPage Today) -- An anti-HIV drug used to prevent mother-to-child transmission of the virus can be safely and effectively given to newborns for up to six months after birth, researchers reported.
hiv drugViramune HIV Infant Prophylaxis Safe (CME/CE)MedPage Today Infectious Disease Thu, 12/22/2011 - 16:30
(MedPage Today) -- An anti-HIV drug used to prevent mother-to-child transmission of the virus can be safely and effectively given to newborns for up to six months after birth, researchers reported. Early trial suggests rectal microbicide is safe, could significa...EurekAlert! - Infectious and Emerging Diseases Sun, 11/06/2011 - 23:00
(University of California - Los Angeles Health Sciences) A topically applied microbicide gel containing a potent anti-HIV drug has been found to significantly reduce infection when applied to rectal tissue that was subsequently exposed to HIV in the laboratory. Tags:
ICAAC: New Drug Easier to Take than HIV Standard (CME/CE)MedPage Today Infectious Disease Thu, 09/22/2011 - 09:00
CHICAGO (MedPage Today) -- The recently approved HIV drug rilpivirine (Edurant) is easier to take for the first three months of therapy than the widely used efavirenz (Sustiva), a researcher said. Quad HIV Drug Passes Hurdle, Maker SaysMedPage Today Infectious Disease Mon, 08/15/2011 - 14:19
(MedPage Today) -- An investigational four-drug HIV pill was not inferior to a widely used single-pill, three-drug antiretroviral combination, according to the company that makes both. Untreated HIV Patients Have New Drug Option (CME/CE)MedPage Today Infectious Disease Thu, 07/14/2011 - 16:30
(MedPage Today) -- The recently approved anti-HIV drug rilpivirine (Edurant) is a new option for people starting treatment for the virus, according to investigators on two randomized controlled trials. ACTHIV: Etravirine Better in Less Treated Patients (CME/CE)MedPage Today Infectious Disease Mon, 04/11/2011 - 07:30
DENVER (MedPage Today) -- An HIV drug approved for heavily pre-treated patients yields better outcomes for those with less treatment experience, a researcher reported here. Novel HIV Drug as Good as Standard, Manufacturer SaysMedPage Today Infectious Disease Wed, 03/23/2011 - 14:53
(MedPage Today) -- The investigational integrase inhibitor elvitegravir performs as well against HIV as the only approved medication in its class, raltegravir (Isentress), according to the drug's maker. Merck Halts Trial of Once-a-Day RaltegravirMedPage Today Infectious Disease Mon, 11/29/2010 - 14:51
(MedPage Today) -- Once-daily use of the anti-HIV drug raltegravir (Isentress) was less effective than the approved twice-daily dosing, Merck announced. Tags:
FDA Adds Cardiac Warning to Saquinavir LabelMedPage Today Infectious Disease Thu, 10/21/2010 - 10:05
(MedPage Today) -- A risk of cardiac arrhythmia when the HIV drug saquinavir (Invirase) is combined with ritonavir (Norvir) will be included in the saquinavir's official prescribing information, the FDA announced. ICAAC: Novel HIV Drug a 'Trade-Off' (CME/CE)MedPage Today Infectious Disease Thu, 09/16/2010 - 09:28
BOSTON (MedPage Today) -- In HIV patients starting therapy, an investigational non-nucleoside reverse transcriptase inhibitor had a higher rate of virologic failure than a standard medication, researchers said here. |